Alliancebernstein L.P. Ultragenyx Pharmaceutical Inc. Transaction History

Alliancebernstein L.P.

  • $290 Billion
  • Q2 2025

A detailed history of Alliancebernstein L.P. transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 1,255,203 shares of RARE stock, worth $40.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,255,203
Previous 1,247,380 0.63%
Holding current value
$40.7 Million
Previous $45.2 Million 1.05%
% of portfolio
0.02%
Previous 0.02%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$31.06 - $39.3 $242,982 - $307,443
7,823 Added 0.63%
1,255,203 $45.6 Million
Q1 2025

May 15, 2025
SELL
$36.21 - $45.78 $13.8 Million - $17.4 Million
-380,552 Reduced 23.38%
1,247,380 $45.2 Million
Q4 2024

Feb 12, 2025
BUY
$42.07 - $57.72 $3.44 Million - $4.71 Million
81,667 Added 5.28%
1,627,932 $68.5 Million
Q3 2024

Nov 14, 2024
BUY
$40.21 - $59.36 $739,461 - $1.09 Million
18,390 Added 1.2%
1,546,265 $85.9 Million
Q2 2024

Aug 14, 2024
BUY
$37.42 - $51.61 $1.7 Million - $2.34 Million
45,404 Added 3.06%
1,527,875 $62.8 Million
Q1 2024

May 14, 2024
SELL
$43.02 - $53.69 $4.14 Million - $5.16 Million
-96,132 Reduced 6.09%
1,482,471 $69.2 Million
Q4 2023

Feb 14, 2024
BUY
$31.73 - $49.19 $1.46 Million - $2.27 Million
46,098 Added 3.01%
1,578,603 $75.5 Million
Q3 2023

Nov 14, 2023
BUY
$34.92 - $46.66 $654,330 - $874,315
18,738 Added 1.24%
1,532,505 $54.6 Million
Q2 2023

Aug 15, 2023
BUY
$37.35 - $52.15 $3.15 Million - $4.4 Million
84,353 Added 5.9%
1,513,767 $69.8 Million
Q1 2023

May 15, 2023
SELL
$36.99 - $48.71 $4.15 Million - $5.47 Million
-112,263 Reduced 7.28%
1,429,414 $57.3 Million
Q4 2022

Feb 14, 2023
BUY
$33.72 - $46.33 $7.69 Million - $10.6 Million
228,144 Added 17.37%
1,541,677 $71.4 Million
Q3 2022

Nov 15, 2022
BUY
$39.96 - $66.14 $3.17 Million - $5.25 Million
79,409 Added 6.43%
1,313,533 $54.4 Million
Q2 2022

Aug 15, 2022
SELL
$45.8 - $85.4 $6.38 Million - $11.9 Million
-139,305 Reduced 10.14%
1,234,124 $73.6 Million
Q1 2022

May 13, 2022
BUY
$62.2 - $84.4 $4.06 Million - $5.51 Million
65,273 Added 4.99%
1,373,429 $99.7 Million
Q4 2021

Feb 14, 2022
BUY
$73.71 - $87.86 $11.2 Million - $13.4 Million
152,002 Added 13.15%
1,308,156 $110 Million
Q3 2021

Nov 10, 2021
SELL
$77.92 - $102.4 $2 Million - $2.63 Million
-25,693 Reduced 2.17%
1,156,154 $104 Million
Q2 2021

Jul 30, 2021
BUY
$92.19 - $115.71 $3.17 Million - $3.98 Million
34,414 Added 3.0%
1,181,847 $113 Million
Q1 2021

May 06, 2021
SELL
$106.9 - $167.73 $4.29 Million - $6.73 Million
-40,136 Reduced 3.38%
1,147,433 $131 Million
Q4 2020

Feb 08, 2021
SELL
$84.4 - $177.39 $16.4 Million - $34.4 Million
-193,983 Reduced 14.04%
1,187,569 $164 Million
Q3 2020

Nov 12, 2020
SELL
$72.98 - $90.0 $2.49 Million - $3.07 Million
-34,144 Reduced 2.41%
1,381,552 $114 Million
Q2 2020

Aug 13, 2020
BUY
$46.91 - $78.22 $124,546 - $207,674
2,655 Added 0.19%
1,415,696 $111 Million
Q1 2020

May 14, 2020
SELL
$33.8 - $62.9 $4.54 Million - $8.45 Million
-134,352 Reduced 8.68%
1,413,041 $62.8 Million
Q4 2019

Feb 18, 2020
BUY
$36.08 - $45.83 $7.64 Million - $9.7 Million
211,635 Added 15.84%
1,547,393 $66.1 Million
Q3 2019

Nov 14, 2019
BUY
$42.5 - $63.11 $7.23 Million - $10.7 Million
170,136 Added 14.6%
1,335,758 $57.1 Million
Q2 2019

Aug 14, 2019
BUY
$54.93 - $74.36 $1.94 Million - $2.63 Million
35,390 Added 3.13%
1,165,622 $74 Million
Q1 2019

May 14, 2019
BUY
$39.87 - $69.36 $4.86 Million - $8.46 Million
122,009 Added 12.1%
1,130,232 $78.4 Million
Q4 2018

Feb 13, 2019
BUY
$38.89 - $77.3 $617,028 - $1.23 Million
15,866 Added 1.6%
1,008,223 $43.8 Million
Q3 2018

Nov 08, 2018
BUY
$71.81 - $90.15 $3.63 Million - $4.55 Million
50,489 Added 5.36%
992,357 $75.8 Million
Q2 2018

Aug 13, 2018
BUY
$48.54 - $85.31 $2.16 Million - $3.8 Million
44,556 Added 4.97%
941,868 $72.4 Million
Q1 2018

May 14, 2018
BUY
$44.33 - $58.52 $8.73 Million - $11.5 Million
196,906 Added 28.11%
897,312 $45.8 Million
Q4 2017

Feb 13, 2018
BUY
$43.54 - $57.32 $2.44 Million - $3.22 Million
56,106 Added 8.71%
700,406 $32.5 Million
Q3 2017

Nov 13, 2017
BUY
$49.79 - $66.32 $32.1 Million - $42.7 Million
644,300
644,300 $34.3 Million

Others Institutions Holding RARE

# of Institutions
362
Shares Held
86.8M
Call Options Held
3.64M
Put Options Held
2.24M
View Full List

About Ultragenyx Pharmaceutical Inc.

RARE Quotes by TradingView
  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $2.27B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email